Rani Therapeutics

Rani Therapeutics is a clinical-stage biotherapeutics company focused on developing its proprietary RaniPill® platform, an orally ingestible capsule designed to replace subcutaneous or intravenous injections of biologics. The technology uses a mechanical process to deliver drug payloads directly into the intestinal wall, where the lack of pain receptors allows for painless administration with bioavailability comparable to injections. The company is actively advancing a pipeline of oral biologics, including biosimilars and novel therapeutics, to address chronic conditions that currently require frequent injections. Rani Therapeutics is headquartered in San Jose, California, and is publicly traded on the NASDAQ.